Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jacques B. de Kok"'
Publikováno v:
Practical Laboratory Medicine, Vol 17, Iss , Pp - (2019)
Objectives: For new analyzers or tests, analytical evaluation is required before implementation in the clinical laboratory. We evaluated the novel Roche Cobas t711 analyzer with six newly developed coagulation assays: the activated partial thrombopla
Externí odkaz:
https://doaj.org/article/75a13063cd22466e8f0cbe8e14fdbbad
Publikováno v:
Journal of pediatric hematology/oncology. 43(7)
Infantile pyknocytosis is a rare and self-limiting cause of hemolytic anemia in neonates. It can result in severe anemia and hyperbilirubinemia. The pathogenesis is unknown: a genetic origin has been discussed; however, based on the current literatur
Publikováno v:
Practical Laboratory Medicine
Practical Laboratory Medicine, Vol 17, Iss, Pp-(2019)
Practical Laboratory Medicine, Vol 17, Iss, Pp-(2019)
Objectives: For new analyzers or tests, analytical evaluation is required before implementation in the clinical laboratory. We evaluated the novel Roche Cobas t711 analyzer with six newly developed coagulation assays: the activated partial thrombopla
Autor:
Marko Babjuk, Iman J. Schultz, Dorine W. Swinkels, J. Mareš, Lambertus A. Kiemeney, Jacques B. de Kok, Kenneth Wester, Huub Straatman, J. Alfred Witjes, Per-Uno Malmström, Johanner L. Willems
Publikováno v:
International Journal of Cancer, 119, 1915-9
International Journal of Cancer, 119, 8, pp. 1915-9
International Journal of Cancer, 119, 8, pp. 1915-9
Contains fulltext : 49679.pdf (Publisher’s version ) (Closed access) Accurate prediction of tumor recurrence in patients with superficial urothelial cell carcinoma (UCC) might result in a significant reduction of invasive follow-up cystoscopies. A
Publikováno v:
Clinica Chimica Acta, 368, 1-2, pp. 20-32
Clinica Chimica Acta, 368, 20-32
Clinica Chimica Acta, 368, 20-32
Contains fulltext : 50926.pdf (Publisher’s version ) (Closed access) Expression of the anti-apoptotic protein survivin is hardly detectable or even absent in many differentiated adult tissues, but is upregulated in almost any type of cancer. Furthe
Autor:
Vivianne C. G. Tjan-Heijnen, Paul N. Span, Fred C.G.J. Sweep, Jacques B. de Kok, J. J. T. M. Heuvel, John A. Foekens
Publikováno v:
Clinical Chemistry, 52, 1693-700
Clinical Chemistry, 52(9), 1693-1700. American Association for Clinical Chemistry Inc.
Clinical Chemistry, 52, 9, pp. 1693-700
Clinical Chemistry, 52(9), 1693-1700. American Association for Clinical Chemistry Inc.
Clinical Chemistry, 52, 9, pp. 1693-700
Background: A total of 4 additional splice variants (survivin-ΔEx3, survivin 2α, survivin-2B, and survivin-3B) have been described for survivin [baculoviral IAP repeat-containing protein (BIRC-5), approved gene symbol BIRC5], which has been implica
Autor:
Petra L.M. Zusterzeel, Eric A.P. Steegers, Erwin T. Wiegerinck, Jacques B. de Kok, Dorine W. Swinkels, Jan C.M. Hendriks
Publikováno v:
Clinical Chemistry. 48:650-653
Fetal DNA in plasma and serum of pregnant women has been reported to be significantly increased in preeclampsia (1)(2). This increase may even precede clinical diagnosis (3). We hypothesized that subsequent development of hemolysis, elevated liver en
Autor:
Dorine W. Swinkels, Jacqueline M. T. Klein Gunnewiek, Rian Roelofs, Yvonne van Aarssen, Jacques B. de Kok, Michael R. van Balken
Publikováno v:
Clinical Chemistry. 46:2003-2007
In patients with superficial urothelial cell carcinomas (UCCs), 80% of tumors recur after transurethral resection. A minority (10–20%) of these recurrent tumors will progress to high-grade and muscle-invasive disease (1). Prediction of progression
Autor:
Jacques B. de Kok, Adrie van Bokhoven, Theo J.M. Ruers, Hans L. Willems, Dorine W. Swinkels, Goos N.P. van Muijen
Publikováno v:
Clinical Chemistry. 46:313-318
Background: Expression of the hTERT gene, which codes for the catalytic subunit of telomerase, is associated with malignancy. We recently developed a real-time reverse transcription-PCR assay, based on TaqMan technology, for accurate and reproducible
Autor:
Jacques B. de Kok, Hans L. Willems, Theo J.M. Ruers, Jack A. Schalken, Tilly Aalders, Dorine W. Swinkels
Publikováno v:
International Journal of Cancer. 87:217-220
Telomerase reverse transcriptase (hTERT) messenger RNA has been detected in 95% of bladder tumors using RT-PCR. In this study, we quantified the expression of hTERT in 35 bladder urothelial cell carcinomas and in 6 normal bladder epithelia using a re